Departments of ∗Neurology
†Internal Medicine, Ziauddin University, Karachi, Pakistan
‡The University of Hong Kong, Hong Kong
§Lahore University of Management Sciences, Lahore, Pakistan
∥Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, MD, TX.
Address correspondence and reprint requests to Maheen Nisar, MBBS, 4/B Shahrah-e-Ghalib Rd, Block 6 Clifton, Karachi, Karachi City, Sindh 75000; E-mail: [email protected]
Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.clinicalneuropharm.com).
ORCID ID. Maheen Nisar: 0000-0003-2541-9177
Muhammad Abdullah Nizam: 0000-0003-1158-0728
Asim Shah: 0000-0003-3343-2777
Zohaib Jawed Abubaker: 0000-0002-2936-0937
Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare.
All authors have given consent for the article to be published in Clinical Neuropharmacology.
Data are provided in manuscript and included in supplementary material.
M.N. conceived and designed the study. The literature search was performed by M.N., Z.J.A., and H.T.S. Analysis and interpretation of the data were conducted by M.A.N., I.A. and M.O.U.R. M.N., Z.J.A., M.S., and H.T.S. prepared the first draft of the manuscript, and it was reviewed critically for intellectual content by A.S. All authors read and approved the final manuscript.
